Filing Details

CUSIP No. 883378101

13G

Page 2 of 5

1

Name of Reporting Persons

I.R.S. Identification Nos. of above persons (entities only).

JADI CELL, LLC

EIN: 30-0711202

2

Check the Appropriate Box if a Member of a Group

(see instructions)

(a) ☐

(b) ☐

3

SEC Use Only

4

Citizenship or Place of Organization

Delaware, United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person with:

5

Sole Voting Power

131,402,390

6

Shared Voting Power

-0-

7

Sole Dispositive Power

131,402,390

8

Shared Dispositive Power

-0-

9

Aggregate Amount Beneficially Owned by Each Reporting Person

131,402,390

10

Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares (see instructions) ☐

11

Percent of Class Represented by Amount in Row 9

4.95% (based on the total of 2,656,578,599 outstanding shares of Common Stock)

12

Type of Reporting Person (see instructions)

OO

CUSIP No. 883378101

13G

Page 3 of 5

Item 1

(a)

Name of Issuer.

Therapeutic Solutions International, Inc., a Nevada corporation

(b)

Address of Issuer’s Principal Executive Offices.

701 Wild Rose Lane

Elk City, ID 83525

Item 2

(a)

Name of Person Filing.

Jadi Cell, LLC

(b)

Address of Principal Business Office, or, if none, Residence.

1100 Biscayne Blvd.

Miami, FL 33132

(c)

Citizenship or Place of Organization.

Delaware

(d)

Title of Class of Securities.

Common stock, par value $0.001 per share (the “Common Stock”).

(e)

CUSIP Number.

883378101

Item 3

If this statement is filed pursuant to §240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

(a)

☐

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);

(b)

☐

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);

(c)

☐

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);

(d)

☐

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C 80a-8);

(e)

☐

An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

(f)

☐

An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

(g)

☐

A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

(h)

☐

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

☐

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

☐

A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

(k)

☐

Group, in accordance with § 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: ____

CUSIP No. 883378101

13G

Page 4 of 5

Item 4

Ownership.

(a)

Amount beneficially owned: 131,402,390.

(b)

Percent of class: 4.95%.

(c)

Number of shares as to which the person has:

(i) Sole power to vote or to direct the vote:  131,402,390

(ii) Shared power to vote or to direct the vote:

(iii) Sole power to dispose or to direct the disposition of: 131,402,390

(iv) Shared power to dispose or to direct the disposition of:

Item 5

Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.

Item 6

Ownership of More Than Five Percent on Behalf of Another Person.

Inapplicable.

Item 7

Identification and Classification of the Subsidiary which Acquired the Security Being Reported On by the Parent Holding Company.

Inapplicable.

Item 8

Identification and Classification of Members of the Group.

Inapplicable.

Item 9

Notice of Dissolution of Group.

Inapplicable.

Item 10

Certification.

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 883378101

13G

Page 5 of 5